RxDoctor Payments DataLook up a doctor →

Larry Alford, MD

Internal Medicine · Birmingham, ALNPI 1386699627

Payments from drug & device makers

$25,184in general payments, 2019–2025

Across 1,543 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AbbVie$3K
  • GSK$2K
  • Boehringer Ingelheim$2K
  • AstraZeneca$2K
  • Lilly USA, LLC$1K
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk205$2,792
AbbVie(2 entities)201$2,516
GSK135$2,389
Boehringer Ingelheim116$2,080
AstraZeneca95$1,758
Lilly USA, LLC91$1,496
Amgen(2 entities)81$1,453
Bayer65$1,177
Pfizer79$1,167
Johnson & Johnson64$1,041
Amarin Pharma, Inc.46$682
Takeda Pharmaceuticals U.S.A., Inc.32$681
Ironwood Pharmaceuticals, Inc19$337
Astellas Pharma US Inc17$303
Sanofi-aventis U.S. LLC16$291
Paratek Pharmaceuticals, Inc.15$277
Kowa Pharmaceuticals America, Inc.19$276
Axsome Therapeutics, Inc.11$267
E.r. Squibb & Sons, L.L.C.14$251
Antares Pharma, Inc.10$227
Merck12$200
Novartis10$198
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$189
Biohaven Pharmaceutical Holding Company Ltd.15$187
Corcept Therapeutics7$170
Biogen8$159
Sunovion Pharmaceuticals Inc.15$150
Esperion Therapeutics, Inc.5$150
Dexcom, Inc.7$145
Ardelyx, Inc.7$142
Radius Health, Inc.7$141
Biohaven Pharmaceuticals, Inc.10$128
Corium, LLC5$117
Otsuka America Pharmaceutical, Inc.6$116
Supernus Pharmaceuticals, Inc.7$110
Eisai Inc.7$101
Abbott5$98
Alkermes, Inc.5$98
Medtronic5$91
Sumitomo Pharma America, Inc.4$87
Lundbeck LLC3$82
Phathom Pharmaceuticals, Inc.4$73
Almatica Pharma LLC3$66
Jazz Pharmaceuticals Inc.3$63
Xeris Pharmaceuticals, Inc.3$60
Teva Pharmaceuticals USA, Inc.4$54
Boston Scientific3$47
Exact Sciences3$46
Vanda Pharmaceuticals Inc.1$39
Shire North American Group Inc2$38
Arbor Pharmaceuticals, Inc.2$32
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$31
Avanir Pharmaceuticals, Inc.2$30
Idorsia Pharmaceuticals US Inc2$29
BETA Bionics, Inc.1$28
Inspire Medical Systems, Inc.1$25
Avion Pharmaceuticals2$23
Genentech USA, Inc.1$21
IBSA Pharma Inc.1$20
Upsher-smith Laboratories LLC1$19

How this compares

$25,184 in reported general payments places this provider in the 95th percentile of 1,533 internal medicine providers in Alabama.

See all internal medicine providers in Alabama →

Medicare billing

Part B allowed, 2024
$208,024
Medicare patients
390
Services billed
6,289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Birmingham

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →